Heterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C)

E Bellos, D Santillo, P Vantourout, JR Jackson, A Duret, H Hearn, Y Seeleuthner, E Talouarn, S Hodeib, H Patel, O Powell, S Yeoh, S Mustafa, D Habgood-Coote, S Nichols, L Estramiana Elorrieta, G D'Souza, VJ Wright, et al.

Research output: Contribution to journalArticlepeer-review

Abstract

Multisystem inflammatory syndrome in children (MIS-C) is a rare condition following SARS-CoV-2 infection associated with intestinal manifestations. Genetic predisposition, including inborn errors of the OAS-RNAseL pathway, has been reported. We sequenced 154 MIS-C patients and utilized a novel statistical framework of gene burden analysis, "burdenMC," which identified an enrichment for rare predicted-deleterious variants in BTNL8 (OR = 4.2, 95% CI: 3.5-5.3, P < 10-6). BTNL8 encodes an intestinal epithelial regulator of Vγ4+γδ T cells implicated in regulating gut homeostasis. Enrichment was exclusive to MIS-C, being absent in patients with COVID-19 or bacterial disease. Using an available functional test for BTNL8, rare variants from a larger cohort of MIS-C patients (n = 835) were tested which identified eight variants in 18 patients (2.2%) with impaired engagement of Vγ4+γδ T cells. Most of these variants were in the B30.2 domain of BTNL8 implicated in sensing epithelial cell status. These findings were associated with altered intestinal permeability, suggesting a possible link between disrupted gut homeostasis and MIS-C-associated enteropathy triggered by SARS-CoV-2.

Original languageEnglish
Article numbere920240699
Number of pages1
JournalJournal of Experimental Medicine (JEM)
Volume221
Issue number12
DOIs
Publication statusPublished - 02 Dec 2024

Fields of science

  • 302035 Paediatrics and adolescent medicine

Cite this